Source:http://linkedlifedata.com/resource/pubmed/id/10574998
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
49
|
pubmed:dateCreated |
2000-2-3
|
pubmed:abstractText |
The transactivating function of the A/B region of mouse peroxisome proliferator-activated receptor alpha (PPARalpha; NR1C1) was characterized. The truncated version of PPARalpha lacking the A/B region had 60-70% lower transactivating function than full-length PPARalpha in both the presence and absence of the peroxisome proliferator ciprofibrate. When tethered to the yeast Gal4 DNA-binding domain, the A/B region exhibited the significant ligand-independent transactivating function, AF-1 activity. The first 44 amino acid residues were necessary for maximal transactivation, and the minimally essential region was further delimited to amino acids 15-44. This region is highly enriched with acidic residues, but mutational analyses showed that the protein structure, rather than the negative charge itself, was important for the AF-1 activity. An alpha-helical configuration was predicted for this region, and a CD spectrum analysis of the synthetic peptides showed that mutant sequences with higher AF-1 activity have higher helical contents and vice versa. The most active mutant, in which Met(31) was replaced with Leu, was approximately 5-fold more potent than the wild-type A/B region. These findings indicate that the AF-1 region of PPARalpha is an acidic activation domain and that the helix-forming property is implicated in the transactivating function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Luciferases,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35152-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10574998-Amino Acid Sequence,
pubmed-meshheading:10574998-Circular Dichroism,
pubmed-meshheading:10574998-HeLa Cells,
pubmed-meshheading:10574998-Humans,
pubmed-meshheading:10574998-Luciferases,
pubmed-meshheading:10574998-Mitogen-Activated Protein Kinases,
pubmed-meshheading:10574998-Molecular Sequence Data,
pubmed-meshheading:10574998-Mutagenesis, Site-Directed,
pubmed-meshheading:10574998-Peptides,
pubmed-meshheading:10574998-Plasmids,
pubmed-meshheading:10574998-Protein Structure, Secondary,
pubmed-meshheading:10574998-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:10574998-Sequence Homology, Amino Acid,
pubmed-meshheading:10574998-Transcription Factors,
pubmed-meshheading:10574998-Transcriptional Activation,
pubmed-meshheading:10574998-Transfection
|
pubmed:year |
1999
|
pubmed:articleTitle |
Characterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor alpha. Importance of alpha-helical structure in the transactivating function.
|
pubmed:affiliation |
Department of Life Science, Faculty of Science, Himeji Institute of Technology, 3-2-1 Koto, Kamigori, Hyogo 678-1297, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|